Compare LPSN & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LPSN | POM |
|---|---|---|
| Founded | 1995 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | EDP Services | Other Specialty Stores |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.0M | 38.8M |
| IPO Year | 2000 | 2025 |
| Metric | LPSN | POM |
|---|---|---|
| Price | $3.28 | $0.30 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 211.4K | ★ 941.2K |
| Earning Date | 03-04-2026 | 12-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $257,660,000.00 | $51,210,721.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.13 |
| 52 Week Low | $2.94 | $0.26 |
| 52 Week High | $23.55 | $6.43 |
| Indicator | LPSN | POM |
|---|---|---|
| Relative Strength Index (RSI) | 35.40 | N/A |
| Support Level | $2.94 | N/A |
| Resistance Level | $4.12 | N/A |
| Average True Range (ATR) | 0.22 | 0.00 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 29.11 | 0.00 |
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.